News and Media
Press Releases
Bloom Science to Participate in Keystone Symposia on Obesity Therapeutics and Microbiome Revolution Symposium
SAN DIEGO, Calif., January 23, 2026 - Bloom Science, Inc., a clinical-stage biotechnology company developing next-generation live biotherapeutic medicines targeting the gut-brain axis, today...
Bloom Science to Participate in J.P. Morgan Healthcare Conference and Sachs Neuroscience Innovation Forum
SAN DIEGO, Calif., January 8, 2026 - Bloom Science, Inc., a clinical-stage biotechnology company developing next-generation live biotherapeutic medicines targeting the gut-brain axis, today...
Bloom Science Engages Epilepsy Community at American Epilepsy Society Meeting 2025
SAN DIEGO, Calif., December 3, 2025 - Bloom Science, Inc., a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders, today announced...
Bloom Science Announces Poster Presentations at Obesity Week 2025
SAN DIEGO, Calif., November 4, 2025 - Bloom Science, Inc., a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders, today announced...
Bloom Science Recognizes Epilepsy Awareness Month
SAN DIEGO, Calif., November 1, 2025 - Bloom Science, recognizes Epilepsy Awareness Month and reaffirms its commitment to advancing innovative therapies for individuals living with epilepsy and...
Bloom Science Recognizes Global ALS/MND Awareness Day and International Dravet Syndrome Awareness Day
SAN DIEGO, Calif., June 21, 2025 - Bloom Science, Inc., a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders, today today...
Bloom Science Reports Positive Data from Phase 1 Trial of BL-001
BL-001 achieved statistically significant placebo-adjusted mean weight loss at 28 days in overweight subjects Overweight individuals in highest dose group experiencing weight loss at day 28...
Christopher Reyes, Founder and CEO of Bloom Science, joins a panel of experts to explore the Science of the Gut-Brain Axis
SAN DIEGO, Calif., August 5, 2024 —Bloom Science, Inc., a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders, today announced that...
Bloom Science to Participate at Upcoming Patient Advocacy Conferences
SAN DIEGO, Calif., June 20, 2024 — Bloom Science, Inc., a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders, today announced that...
Bloom CEO Christopher Reyes, PhD Patriciates on IamBIO podcast Focused on Exploring the Science of the Microbiome
SAN DIEGO, Calif., March 12, 2024 —The gut microbiome plays a crucial role in our health. However, there is still much to learn about this complex ecosystem. In today's IamBIO episode, Bloom’s CEO...
Bloom Science to Present at the Sachs 8th Annual Neuroscience Innovation Forum
SAN DIEGO, Calif., January 10, 2025 - Bloom Science, Inc., a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders, today announced...
Bloom Science to Present at the Sachs 1st Annual Biopharma Obesity Innovation Forum
SAN DIEGO, Calif., January 9, 2025 - Bloom Science, Inc., a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders, today announced...